The new study looked at 58 lung transplant patients who were randomized to receive either 300 mg of aerosol cyclosporine or aerosol placebo. Inhale three days per week for the first two years after their transplantation Both groups received oral anti – rejection medication .

The findings from the same study who got so far found that inhaled cyclosporine improved survival rate and prolonged survival of chronic rejection in lung transplant patients. These findings were England Journal of Medicine England Journal of Medicine in January 2006.

The EMS departments followed data transfers in ,, systems in cardiac arrest outside the hospital experience all the way through discharge from the hospital. If the new new CPR technology including use of the impedance threshold device ResQPOD , the discharge from hospital rates were from 7.9 % to 15.7 %, and doubled survival of control group. – Bernd Aufderheide said, ‘The menu on interventions in patients with heart failure into among the highest survival rate ever been documented in for this devastating disease, results.